Home › Pancreatic Cancer › New York › New York City
Pancreatic Cancer clinical trials in New York City, NY
60 studies for Pancreatic Cancer are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RecruitingPhase 1/2
- Research Site, New York
- Research Site, New York
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 3
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Recruiting
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RecruitingPhase 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- and 2 more
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RecruitingPhase 2
- Memorial Sloan Kettering Hospital, New York
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RecruitingPhase 3
- Columbia University Irving Medical Center, New York
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Columbia University Irving Medical Center, New York
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- NYU Langone Medical Center, New York
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- Icahn School of Medicine at Mount Sinai, New York
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 3
- Laura and Issac Perlmutter Cancer Center at NYU Langone-Ambulatory Care Center, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- and 1 more
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RecruitingPhase 3
- Investigative Site US031, New York
- Investigative Site US003, New York
- Investigative Site US041, New York
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RecruitingPhase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center Main Campus, New York
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- Columbia University, New York
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecruitingPhase 1/2
- NYU Langone Health Perlmutter Cancer Center, New York
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecruitingPhase 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RecruitingPhase 2
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RecruitingPhase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RecruitingPhase 2
- NYU-Manhattan, New York
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecruitingPhase 1
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Recruiting
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
RecruitingPhase 1/2
- Mount Sinai Hospital, New York
- NYP/Weill Cornell Medical Center, New York
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
Recruiting
- NYU Langone Health, New York
- Lenox hill Hospital, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
RecruitingPhase 1
- New York Cancer & Blood Specialists, New York
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- Mount Sinai West, New York
- Mount Sinai Hospital, New York
- and 2 more
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan - Kettering Cancer Center, New York
- Memorial Sloan Kettering Basking Ridge (All protocol activities), New York
- Weill Cornell Medical Center, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RecruitingPhase 1
- Investigative Site #103, New York
- Investigative Site #106, New York
Pancreatic Cancer Early Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
- Icahn School of Medicine At Mount Sinai, New York
- Columbia University Irving Medical Center, New York
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
RecruitingPhase 2
- NYU Langone Health Perlmutter Cancer Center, New York
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
RecruitingPhase 2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
RecruitingObservational study
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RecruitingPhase 1/2
- NYU Langone Medical Center, New York
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecruitingPhase 1
- Research Site, New York
- Research Site, New York
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecruitingPhase 1
- NYU Langone, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecruitingPhase 1/2
- Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan-Kettering Cancer Center, New York
- Columbia University, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
RecruitingPhase 1
- Columbia University Irving Medical Center, New York
Pancreatic Cancer Genetics
RecruitingObservational study
- Columbia University Medical Center, New York
A Study of MGC028 in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Icahn School of Medicine at Mt. Sinai, New York
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecruitingPhase 1/2
- Laura & Isaac Perlmutter Cancer Center at NYU Langone, New York
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Medical Center, New York
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer
RecruitingPhase 1/2
- Columbia University Irving Medical Center, New York
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University-Telemedicine, New York
Pancreas Registry and High Risk Registry
RecruitingObservational study
- Mount Sinai West, New York
- Icahn School of Medicine at Mount Sinai, New York
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center, New York
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
RecruitingPhase 1
- Memorial Sloan Kettering Cancer Center, New York
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
RecruitingObservational study
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
A Study of Multiparametric Ultrasound Imaging Methods
RecruitingHealthy volunteers welcome
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Weill Cornell Medicine, Cornell University (site 126), New York
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 1
- Tisch Hospital, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, New York
The Cancer of the Pancreas Screening-5 CAPS5)Study
RecruitingPhase 3
- NYU Langone Medical Center, New York
- Columbia University Medical Center, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #5, New York
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
RecruitingObservational study
- Icahn School of Medicine at Mount Sinai, New York
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
RecruitingPhase 1
- Memorial Sloan Kettering, New York
- Columbia University Herbert Irving Comprehensive Cancer Center, New York
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma
RecruitingPhase 2
- Columbia University Medical Center, New York
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
RecruitingPhase 2/3
- Columbia University Medical Center, New York
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
RecruitingPhase 2
- Icahn School of Medicine at Mount Sinai, New York
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX61 studies
- Boston, MA43 studies
- Nashville, TN39 studies
- Los Angeles, CA35 studies
- St. Louis, MO33 studies
- Arlington, VA33 studies
- Baltimore, MD31 studies
- San Antonio, TX31 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- Durham, NC24 studies
- San Diego, CA24 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
- Heart Failure51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.